deferoxamine has been researched along with cyclic gmp in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, J; Rikihisa, Y | 1 |
| Kontos, HA; Marshall, JJ; Wei, EP | 1 |
| Dawson, R; Felheim, R; Nguyen, S | 1 |
| Catravas, JD; Marczin, N; Ryan, US | 1 |
| Farinelli, SE; Greene, LA; Park, DS; Stefanis, L; Yan, CY | 1 |
| Graier, WF; Kostner, GM; Kukovetz, WR; Simecek, S | 1 |
| Barrett, KE; Ries, J; Stein, J; Traynor-Kaplan, AE | 1 |
| Bunn, HF; Goldberg, MA; Gu, J; Huang, LE; Willmore, WG | 1 |
| Abate, A; Oberle, S; Schröder, H; Schwartz, P | 1 |
| Branco, LG; Nascimento, CG | 1 |
| Chang, JH; Choi, JH; Choi, SH; Chun, BG; Kim, DH; Yun, IJ | 1 |
| Scholz, PM; Tan, T; Weiss, HR | 1 |
| Dou, D; Gao, Y; Liu, J; Xu, X; Ye, L; Zheng, X | 1 |
13 other study(ies) available for deferoxamine and cyclic gmp
| Article | Year |
|---|---|
L-arginine-dependent killing of intracellular Ehrlichia risticii by macrophages treated with gamma interferon.
Topics: Animals; Arginine; Cyclic GMP; Deferoxamine; Ehrlichia; Female; Interferon-gamma; Macrophages; Mice; Nitric Oxide; Nitrites; Nitroprusside; omega-N-Methylarginine | 1992 |
Independent blockade of cerebral vasodilation from acetylcholine and nitric oxide.
Topics: Acetylcholine; Animals; Arterioles; Catalase; Cats; Cerebrovascular Circulation; Cyclic GMP; Deferoxamine; Methylene Blue; Nitric Oxide; Nitroblue Tetrazolium; Reference Values; Superoxide Dismutase; Vasodilation | 1988 |
Mechanism of sodium nitroprusside-mediated inhibition of aromatic amino acid decarboxylase activity.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Cells, Cultured; Cyclic GMP; Deferoxamine; Dopamine; Ferrous Compounds; Glutathione; In Vitro Techniques; Kidney; Nitroprusside; Potassium Cyanide; Pyridoxal Phosphate; Rats; Swine | 1995 |
Sulfhydryl-depleting agents, but not deferoxamine, modulate EDRF action in cultured pulmonary arterial cells.
Topics: Animals; Cells, Cultured; Cyclic GMP; Deferoxamine; Endothelium, Vascular; Muscle, Smooth, Vascular; Nitric Oxide; Nitro Compounds; Pulmonary Artery; Sulfhydryl Reagents; Vasodilator Agents | 1993 |
Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells.
Topics: Acetylcysteine; Animals; Apoptosis; Apoptosis Regulatory Proteins; Aurintricarboxylic Acid; Calcium-Calmodulin-Dependent Protein Kinases; Carrier Proteins; Caspase 1; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cysteine Endopeptidases; Dactinomycin; Deferoxamine; Enzyme Activation; Humans; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Nerve Growth Factors; PC12 Cells; Rats; RNA; Serpins; Viral Proteins | 1996 |
High D-glucose-induced changes in endothelial Ca2+/EDRF signaling are due to generation of superoxide anions.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Aorta; Bradykinin; Calcium; Cells, Cultured; Cyclic GMP; Cytochalasin B; Deferoxamine; Econazole; Endothelium, Vascular; Enzyme Inhibitors; Glucose; Gossypol; Imidazoles; Imidazolidines; Indomethacin; Kinetics; Masoprocol; Miconazole; Nitric Oxide; Nitric Oxide Synthase; Signal Transduction; Superoxides; Swine; Time Factors | 1996 |
Dual role for AlF4(-)-sensitive G proteins in the function of T84 epithelial cells: transport and barrier effects.
Topics: Actins; Aluminum Compounds; Biological Transport; Calcium; Cyclic AMP; Cyclic GMP; Deferoxamine; Epithelium; Fluorides; GTP-Binding Proteins; Humans; Intestinal Mucosa; Permeability; Tumor Cells, Cultured; Type C Phospholipases | 1997 |
Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling.
Topics: Aryl Hydrocarbon Receptor Nuclear Translocator; Carbon Monoxide; Cell Hypoxia; Cell Line; Cobalt; Cyclic GMP; Cysteine; Deferoxamine; DNA-Binding Proteins; Erythropoietin; Gene Expression Regulation; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Nitric Oxide; Nitroprusside; Nuclear Proteins; Oxygen; Receptors, Aryl Hydrocarbon; RNA, Messenger; Transcription Factors; Transcriptional Activation; Transfection | 1999 |
The antioxidant defense protein ferritin is a novel and specific target for pentaerithrityl tetranitrate in endothelial cells.
Topics: Animals; Antioxidants; Aorta; Cells, Cultured; Cyclic GMP; Cyclic N-Oxides; Deferoxamine; Endothelium, Vascular; Ferritins; Free Radical Scavengers; Gene Expression; Guanylate Cyclase; Imidazoles; Iron Chelating Agents; Isosorbide Dinitrate; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Pentaerythritol Tetranitrate; Spermine; Swine | 1999 |
Role of the peripheral heme oxygenase-carbon monoxide pathway on the nociceptive response of rats to the formalin test: evidence for a cGMP signaling pathway.
Topics: Animals; Biliverdine; Carbon Monoxide; Cyclic GMP; Deferoxamine; Deuteroporphyrins; Heme; Heme Oxygenase (Decyclizing); Iron Chelating Agents; Lysine; Male; Pain; Pain Measurement; Rats; Rats, Wistar; Signal Transduction | 2007 |
Zaprinast inhibits hydrogen peroxide-induced lysosomal destabilization and cell death in astrocytes.
Topics: Animals; Animals, Newborn; Astrocytes; Cathepsin D; Cell Death; Cells, Cultured; Cerebral Cortex; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cytoprotection; Cytosol; Deferoxamine; Dose-Response Relationship, Drug; Hydrogen Peroxide; Intracellular Membranes; L-Lactate Dehydrogenase; Lysosomes; Membrane Potential, Mitochondrial; Mitochondria; Oxidative Stress; Phosphodiesterase Inhibitors; Protective Agents; Purinones; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Rotenone; Sphingosine; Thionucleotides; Uncoupling Agents | 2007 |
Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes.
Topics: Animals; Carbazoles; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Deferoxamine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nitric Oxide; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Up-Regulation | 2010 |
Hydrogen peroxide enhances vasodilatation by increasing dimerization of cGMP-dependent protein kinase type Iα.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Amitrole; Animals; Aorta; Blood Pressure; Blotting, Western; Catalase; Coronary Vessels; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Deferoxamine; Dimerization; Dose-Response Relationship, Drug; Enzyme Activation; Hydrogen Peroxide; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Swine; Vasodilation; Vasodilator Agents | 2012 |